Galectins in Modulating Immune Responsiveness of IgE-bearing Cells

半乳糖凝集素调节 IgE 细胞的免疫反应

基本信息

  • 批准号:
    10651597
  • 负责人:
  • 金额:
    $ 52.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-19 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Allergic diseases are caused by skewed immune responses to otherwise harmless antigens, and, in one form or another, affect up to 25% of the population in the United States, with a disproportionately increase especially among children with asthma and food-related hypersensitivities. The binding of specific IgE to cells bearing high affinity receptors (FcεRI) is hallmark for the pathogenesis of allergic disease in that subsequent interaction with allergen causes cells such as basophils, mast cells, and dendritic cells to release pro-inflammatory mediators and cytokines that promote and/or amplify disease. In particular, crosslinking of IgE/FcεRI triggers basophils to release histamine and LTC4 but also IL-4 and IL-13 – mediators and cytokines central to the allergic diathesis. More recently, these activities have been confirmed and extended in vivo using mouse models, with some showing evidence for an “axis” whereby epithelial cell (EC)-derived cytokines activate basophils to produce IL-4 (& IL-13). In contrast, confirmatory results of these EC cytokines activating human basophils have not been forthcoming. In exploring this translational discrepancy, we serendipitously uncovered a remarkably robust, and potentially unique, mode of EC-dependent activation of human basophils that requires cell-to-cell adhesion and is IgE-dependent. Preliminary data now point to this mode of activation (discovered after co-culturing basophils with A549-lung EC) as being mediated by galectin-3 (Gal-3) –a lectin long known to bind IgE. There is also rationale for yet another level of regulation to this response –one mediated by Gal-9, which also binds IgE with nearly 100- fold greater affinity than does Gal-3 but lacks IgE/FcεRI crosslinking capabilities. Aim 1 studies further characterize the parameters underlying EC-dependent activation of basophils, with the goal of extending Gal-3-dependent activation to include primary human epithelial cells (PHEC). The Gal-3/Gal-9 interplay is also to be addressed in PHEC using genetic manipulation as well as a model whereby microspheres are coated with these galectins. Signaling pathways will also be explored and are thought to differ from those associated with standard anaphylactic release. Aim 2 will test the hypothesis that Gal-3/9 interplay also regulates the activities of other IgE-bearing cells, with preliminary evidence that Gal-3 also induces DC subtypes to secrete large quantities of pro-inflammatory cytokines (i.e. TNF-α/IL-6). Finally, Aim-3 investigates the regulation of Gal3/9 on EC, hypothesizing that their expression is counter-regulated by pro- inflammatory cytokines/mediators vs. innate immune stimuli. Overall, these results could ultimately provide insight into several unexplained IgE-related phenomena for which these IgE-bearing cells and Gal-3 are all implicated, ranging from allergic disease (e.g. asthma, chronic urticaria, and atopic dermatitis) to non- allergic conditions, including autoimmunity (lupus nephritis), cancer, and conceivably wound healing.
过敏性疾病是由免疫系统对无害抗原的扭曲反应引起的

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Basophils from allergy to cancer.
从过敏到癌症的嗜碱性粒细胞。
  • DOI:
    10.3389/fimmu.2022.1056838
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
Is There a Role for Basophils in Cancer?
  • DOI:
    10.3389/fimmu.2020.02103
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Marone G;Schroeder JT;Mattei F;Loffredo S;Gambardella AR;Poto R;de Paulis A;Schiavoni G;Varricchi G
  • 通讯作者:
    Varricchi G
The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3.
  • DOI:
    10.3389/fimmu.2022.831763
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Schroeder JT;Bieneman AP
  • 通讯作者:
    Bieneman AP
Epithelial Cell-Associated Galectin-3 Activates Human Dendritic Cell Subtypes for Pro-Inflammatory Cytokines.
  • DOI:
    10.3389/fimmu.2020.524826
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Schroeder JT;Adeosun AA;Bieneman AP
  • 通讯作者:
    Bieneman AP
Basophils beyond allergic and parasitic diseases.
  • DOI:
    10.3389/fimmu.2023.1190034
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN T. SCHROEDER其他文献

JOHN T. SCHROEDER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN T. SCHROEDER', 18)}}的其他基金

Epithelial Cell-dependent Activation of Human Basophils
人类嗜碱性粒细胞的上皮细胞依赖性激活
  • 批准号:
    9179854
  • 财政年份:
    2016
  • 资助金额:
    $ 52.23万
  • 项目类别:
Plasma Serum Based Biomarkers in Sublingual Oral Immunotherapy for Milk Allergy
基于血浆血清的生物标志物用于舌下口服免疫疗法治疗牛奶过敏
  • 批准号:
    8424318
  • 财政年份:
    2012
  • 资助金额:
    $ 52.23万
  • 项目类别:
Plasma Serum Based Biomarkers in Sublingual Oral Immunotherapy for Milk Allergy
基于血浆血清的生物标志物用于舌下口服免疫疗法治疗牛奶过敏
  • 批准号:
    8241529
  • 财政年份:
    2012
  • 资助金额:
    $ 52.23万
  • 项目类别:
Basophils in Modulating Th2 Responses in Human Allergic Disease
嗜碱性粒细胞调节人类过敏性疾病中的 Th2 反应
  • 批准号:
    8308732
  • 财政年份:
    2011
  • 资助金额:
    $ 52.23万
  • 项目类别:
Immune Cell Responses in Food Hypersensitivity
食物过敏中的免疫细胞反应
  • 批准号:
    7640656
  • 财政年份:
    2008
  • 资助金额:
    $ 52.23万
  • 项目类别:
Immune Cell Responses in Food Hypersensitivity
食物过敏中的免疫细胞反应
  • 批准号:
    7536279
  • 财政年份:
    2008
  • 资助金额:
    $ 52.23万
  • 项目类别:
Innate Immune Function of FcERI-Bearing Cells
携带 FcERI 的细胞的先天免疫功能
  • 批准号:
    7150228
  • 财政年份:
    2006
  • 资助金额:
    $ 52.23万
  • 项目类别:
Differential Cytokine Secretion by Human Basophils
人类嗜碱性粒细胞的差异细胞因子分泌
  • 批准号:
    6856521
  • 财政年份:
    1998
  • 资助金额:
    $ 52.23万
  • 项目类别:
DIFFERENTIAL CYTOKINE SECRETION BY BASOPHILS
嗜碱性粒细胞分泌的差异细胞因子
  • 批准号:
    2887635
  • 财政年份:
    1998
  • 资助金额:
    $ 52.23万
  • 项目类别:
Differential Cytokine Secretion by Human Basophils
人类嗜碱性粒细胞的差异细胞因子分泌
  • 批准号:
    7191604
  • 财政年份:
    1998
  • 资助金额:
    $ 52.23万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了